The collaborative efforts of Domainex and Auspherix have made new progress in the development of a solution to the growing threat of antibiotic resistance. New data was presented by Domainex’s Jonathan Powell at the 19th RSC/SCI Medicinal Chemistry Symposium in Cambridge, UK, outlining the discovery of three distinct chemical series that have shown promise in this area.